Microneedle array delivery of Yersinia pestis recapitulates bubonic plague

Sarah L Price1, Robert S Oakes2,3, Rodrigo J Gonzalez4,5

  • 1Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

Iscience
|January 5, 2024
PubMed

Insights

Microneedle arrays (MNAs) offer a safer method for studying bubonic plague by enabling direct dermal inoculation of Yersinia pestis. This technique overcomes the risks associated with traditional needle injections, improving laboratory safety and research efficiency.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Fleas transmit Yersinia pestis, the causative agent of bubonic plague, directly into mammalian dermis.
  • Syringe-mediated intradermal inoculation is standard for Y. pestis research but poses risks to laboratory personnel.

Purpose of the Study:

  • To evaluate microneedle arrays (MNAs) as a safe and effective alternative for Y. pestis dermal inoculation.
  • To characterize Y. pestis pathogenesis and host-pathogen interactions using MNA delivery.

Main Methods:

  • Development and application of MNA technology for controlled Y. pestis dermal delivery in a mouse model.
  • Live-animal optical imaging to track infection progression.
  • Assessment of Y. pestis interaction with host immune factors, specifically calprotectin-mediated zinc restriction.

Main Results:

  • MNA inoculation successfully recapitulated lethal bubonic plague in mice.
  • Defined parameters for establishing Y. pestis infection via MNA delivery.
  • Demonstrated Y. pestis must overcome dermal zinc restriction and identified vaccine potential for attenuated mutants delivered via MNA.

Conclusions:

  • Microneedle arrays provide a safe and viable alternative to syringe inoculation for studying Y. pestis pathogenesis.
  • MNA technology facilitates research into bacterial virulence mechanisms and potential vaccine development.

Related Concept Videos